「必要なサポートは、ここで見つかります。」というメッセージ

    必要なサポートは、
    ここで見つかります

    ツールオーダー

    ウルトラツールオーダーのアイコン

    かんたん申込みで、“無料”お届け！

    服用時に使用するドジョルビ専用の計量用アクセサリーセットをこちらからお申込みいただけます。

    ドジョルビ服用時のシリンジ３本・カップ１個・プレスインボトルアダプター１個・取扱説明書がセットの商品の画像

    ドジョルビ専用の計量用アクセサリーセット

    計量用シリンジ３本・計量カップ１個・プレスインボトルアダプター１個・取扱説明書のセットです。

    計量用アクセサリーセットを申し込む

    ドジョルビのサポートツールを
    ダウンロード

    ドジョルビ服用ダイアリー
    プラス（見本）

    ダダウンロード版の服用ダイアリーです。
    ドジョルビの服用量や服用回数、体調の変化などを記録することができます。

    ドジョルビ服用日誌のダウンロード用のサムネイル

    PDF版をダウンロード

    LC-FAOD疾患説明冊子

    長鎖脂肪酸代謝異常症（LC-FAOD）について、原因や症状、日常生活での注意点などをわかりやすく説明しています。

    長鎖脂肪酸代謝異常症（LC-FAOD）を正しく理解するためにの冊子ダウンロード用のサムネイル

    PDF版をダウンロード

    医療費助成制度についての
    解説冊子

    LC-FAODと診断された後に知っておきたい医療費助成制度や手続きについて、やさしくまとめた冊子です。

    医療費助成制度についての冊子ダウンロードサムネイル

    ドジョルビ服用サポートブック

    ドジョルビの服用方法や注意点などを、ご本人とご家族の方にもわかりやすく説明しています。

    ドジョルビ服用サポートブックの冊子ダウンロードサムネイル

    PDF版をダウンロード

    ドジョルビの計量方法

    ドジョルビ（トリヘプタノイン）投与の準備ビデオ

    ドジョルビを計量して薬瓶から取り出すために必要な計量のためのアクセサリーの使い方を動画で説明しています。

    ドジョルビの飲食物への混合方法

    ドジョルビを半固形食や液体に混ぜる方法を動画で説明しています。

    （乳化できる低脂肪または無脂肪製品の例として、米国の添付文書に記載されている、無脂肪乳・無脂肪ヨーグルト・全粒穀物入りホットシリアル・スムージーを紹介しています）

     
    ドジョルビ（トリヘプタノイン）を食品に混ぜるビデオシリーズ

    患者コミュニティを見つける

    ひだまりたんぽぽのサムネイル

    ひだまりたんぽぽ
    LC-FAODの患者家族会

    FAOD組織

    Stay Informed

    Connect with us to get the latest information on LC-FAOD and/or DOJOLVI.

    *Required fields

    By submitting this form, you agree to allow Ultragenyx and its agents to collect the information provided and to be contacted directly by an Ultragenyx representative. Your information will not be used for any other purpose than for a representative to respond to your information request or for us to send you other DOJOLVI updates if you have registered to receive them.

    Ultragenyx will not sell, rent, or otherwise distribute your name and any personally identifiable information outside of Ultragenyx and its agents. Ultragenyx will only use your information in accordance with its Privacy Policy.

    What is DOJOLVI?

    DOJOLVI is a prescription medicine used to treat long-chain fatty acid oxidation disorders (LC-FAOD) in children and adults.

    IMPORTANT SAFETY INFORMATION

    Before taking DOJOLVI, tell your healthcare provider about all of your medical conditions, including if you:

    • are pregnant or plan to become pregnant. It is not known if DOJOLVI will harm your unborn baby. Pregnancy Safety Study: There is a pregnancy safety study for women who take DOJOLVI during pregnancy. The purpose of this study is to collect information about your health and your baby's health. You can talk to your healthcare provider or contact 1-888-756-8657 to enroll in this study or get more information.
    • are breastfeeding or plan to breastfeed. It is not known if DOJOLVI passes into breast milk. Talk to your healthcare provider about the best way to feed your baby if you take DOJOLVI.
    • are taking a pancreatic lipase inhibitor, such as orlistat, as it may affect how well DOJOLVI works.

    Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

    What are the possible side effects of DOJOLVI?

    • Feeding tube problems. Feeding tubes may not work as well or stop working over time when taking DOJOLVI. Do not use DOJOLVI in feeding tubes made of polyvinyl chloride (PVC). Check the feeding tube to make sure it is working properly and not breaking down.
    • Intestinal absorption problems in patients with pancreatic insufficiency. If you have pancreatic insufficiency, consult with your healthcare provider as it may affect how well DOJOLVI works.
    • The most common side effects of DOJOLVI include:
      • stomach (abdominal) pain
      • diarrhea
      • vomiting
      • nausea

    These are not all the possible side effects of DOJOLVI. Call your healthcare provider for medical advice about side effects. You may report side effects to Ultragenyx Pharmaceutical Inc. at 1-888-756-8657 or FDA at 1-800-FDA-1088.

    Please see full Prescribing Information, including Patient Information, for additional important safety information and instructions for use.

    LESS -

    What is DOJOLVI?

    DOJOLVI is a prescription medicine used to treat long-chain fatty acid oxidation disorders (LC-FAOD) in children and adults.

    IMPORTANT SAFETY INFORMATION

    Before taking DOJOLVI, tell your healthcare provider about all of your medical conditions, including if you:

    • are pregnant or plan to become pregnant. It is not known if DOJOLVI will harm your unborn baby. Pregnancy Safety Study: There is a pregnancy safety study for women who take DOJOLVI during pregnancy. The purpose of this study is to collect information about your health and your baby's health. You can talk to your healthcare provider or contact 1-888-756-8657 to enroll in this study or get more information.
    • are breastfeeding or plan to breastfeed. It is not known if DOJOLVI passes into breast milk. Talk to your healthcare provider about the best way to feed your baby if you take DOJOLVI.
    • are taking a pancreatic lipase inhibitor, such as orlistat, as it may affect how well DOJOLVI works.

    Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

    What are the possible side effects of DOJOLVI?

    • Feeding tube problems. Feeding tubes may not work as well or stop working over time when taking DOJOLVI. Do not use DOJOLVI in feeding tubes made of polyvinyl chloride (PVC). Check the feeding tube to make sure it is working properly and not breaking down.
    • Intestinal absorption problems in patients with pancreatic insufficiency. If you have pancreatic insufficiency, consult with your healthcare provider as it may affect how well DOJOLVI works.
    • The most common side effects of DOJOLVI include:
      • stomach (abdominal) pain
      • diarrhea
      • vomiting
      • nausea

    These are not all the possible side effects of DOJOLVI. Call your healthcare provider for medical advice about side effects. You may report side effects to Ultragenyx Pharmaceutical Inc. at 1-888-756-8657 or FDA at 1-800-FDA-1088.

    Please see full Prescribing Information, including Patient Information, for additional important safety information and instructions for use.

    MORE +